Development of docetaxel-loaded PEG–PLA nanoparticles using surfactant-free method for controlled release studies

References

• IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, vol. 90. International Agency for Research on Cancer, 2007, France. Accessed at September 2016. http://monographs.iarc.fr/.
   Google Scholar
• WHO (World Health Organization). Human Papillomaviruses. Accessed at September 2016. http://www.who.int/vaccine_research/diseases/viralcancers/en/index3.html.
   Google Scholar
• Ji, J.; Zuo, P.; Wang, Y. L. Enhanced anti-proliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticles. Nanoscale Res. Lett. 2015, 10, 453. doi:10.1186/s11671-015-1162-2
   PubMed Web of Science ®Google Scholar
• Schiller, J. T.; Castellsagué, X.; Villa, L. L.; Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 2008, 26(Suppl 10), K53.
   PubMed Web of Science ®Google Scholar
• Qiu, B.; Ji, M.; Song, X.; Zhu, Y.; Wang, Z.; Zhang, X.; Wu, S.; Chen, H.; Mei, L.; Zheng, Y. Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer. Nanoscale Res. Lett. 2012, 7, 666.
   PubMed Web of Science ®Google Scholar
• Takekida, S.; Fujiwara, K.; Nagao, S.; Yamaguchi, S.; Yoshida, N.; Kitada, F.; Junzo, K.; Naoki, T.; Ryuichiro, N. Phase II study of combination chemotherapy with docetaxel and carboplatin for locally advanced or recurrent cervical cancer. Int. J. Gynecol. Cancer 2010, 20, 1563.
   PubMed Web of Science ®Google Scholar
• Garcia, A. A.; Blessing, J. A.; Vaccarello, L.; Roman, L. D. Gynecologic oncology group study. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a gynecologic oncology group study. Am. J. Clin. Oncol. 2007, 30, 428.
   PubMed Web of Science ®Google Scholar
• https://clinicaltrials.gov/ct2/show/NCT41093.
   Google Scholar
• http://www.cancer.gov/about-cancer/treatment/drugs/docetaxel.
   Google Scholar
• Engelsa, F. K.; Mathotb, R. A. A.; Verweija, J. Alternative drug formulations of docetaxel: a review. Anticancer Drugs 2007, 18, 95.
   PubMed Web of Science ®Google Scholar
• Baker, J.; Ajani, J.; Scotte, F.; Winther, D.; Martin, M.; Aapro, M. S.; von Minckwitz, G. Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs. 2009, 13, 49.
   PubMed Web of Science ®Google Scholar
• Liu, B.; Yang, M.; Li, R.; Ding, Y.; Qian, X.; Yu, L.; Jiang, X. The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur. J. Pharm. Biopharm. 2008, 69, 527.
   PubMed Web of Science ®Google Scholar
• Shirakawa, K.; Takara, K.; Tanigawara, Y.; Aoyama, N.; Kasuga, M.; Komada, F.; Sakaeda, T.; Okumura, K. Interaction of docetaxel (‘Taxotere’) with human P-glycoprotein. Jpn. J. Cancer Res. 1999, 90, 1380.
   PubMedGoogle Scholar
• Lin, J. H. Drug–drug interaction mediated by inhibition and induction of P-glycoprotein. Adv. Drug Deliv. Rev. 2003, 55, 53.
   PubMed Web of Science ®Google Scholar
• Dey, R. K.; Mishra, P.; Barik, A.; Parhi, P. Poly(ethylene glycol)–poly(lactic acid) polymeric micelles as novel drug delivery system in cancer therapy: an overview. Trends Biomater. Artif. Organs 2016, 30(1), 140–150.
   Google Scholar
• Xiao, L.; Xiong, X.; Sun, X.; Zhu, Y.; Yang, H.; Chen, H.; Gan, L.; Xu, H.; Yang, X. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles. Biomaterials 2011, 32, 5148.
   PubMed Web of Science ®Google Scholar
• Lee, S. W.; Yun, M. H.; Jeong, S. W.; In, C. H.; Kim, J. Y.; Seo, M. H.; Pai, C. M.; Kim, S. O. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. J. Control. Release 2011, 155, 262.
   PubMed Web of Science ®Google Scholar
• Liu, D.; Wang, L.; Liu, Z.; Zhang, C.; Zhang, N. Preparation, characterization and in vitro evaluation of docetaxel-loaded poly(lactic acid)–poly(ethylene glycol) nanoparticles for parenteral drug delivery, J. Biomed. Nanotechnol. 2010, 6, 675.
   PubMed Web of Science ®Google Scholar
• Aryal, S.; Hu, C. M. J.; Zhang, L. Polymer–cisplatin conjugate nanoparticles for acid-responsive drug delivery. ACS Nano 2010, 4, 251.
   PubMed Web of Science ®Google Scholar
• Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X.; Nissenbaum, E.-L.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007, 28, 869.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Yang, F.; Chen, W.; Liu, J.; Huang, W.; Jin, M.; Gao, Z. A novel monomethoxy polyethylene glycol–polylactic acid polymeric micelles with higher loading capacity for docetaxel; and well reconstitution characteristics; and its anti-metastasis study. Chem. Pharm. Bull. 2012, 60(9), 1146.
   PubMed Web of Science ®Google Scholar
• Wang, H.; Zhao, Y.; Wua, Y.; Hu, Y. I.; Nan, K.; Nie, G.; Chen, H. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG–PLGA copolymer nanoparticles. Biomaterials 2011, 32, 8281.
   PubMed Web of Science ®Google Scholar
• Mishra, P.; Senthivinayagam, S.; Rangasamy, V.; Sondarva, G.; Rana, B. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation. Mol. Endocrinol. 2010, 24, 598.
   PubMed Web of Science ®Google Scholar
• Kaczmarek, H.; Vukovi!-Kwiatkowska, I. Preparation and characterization of interpenetrating networks based on polyacrylates and poly(lactic acid). eXPRESS Polym. Lett. 2012, 6, 78.
   Web of Science ®Google Scholar
• Patil, Y. B.; Toti, U. S.; Khdair, A.; Ma, L.; Panyam, J. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery. Biomaterials 2009, 30, 859.
   PubMed Web of Science ®Google Scholar
• Wu, C.-S.; Liao, H.-T. Study on the preparation and characterization of biodegradable polylactide/multi-walled carbon nanotubes nanocomposites. Polymer 2007, 48, 4449.
   Web of Science ®Google Scholar
• Hami, Z.; Amini, M.; Khansari, M. G.; Rezayat, S. M.; Gilani, K. Synthesis and in vitro evaluation of a pH-sensitive PLA–PEG-folate based polymeric micelle for controlled delivery of docetaxel. Colloids Surf. B Biointerfaces 2014, 116, 309.
   PubMed Web of Science ®Google Scholar
• Govender, T.; Stolnik, S.; Garnett, M C.; Illum, L.; Davis, S. S. PLGA nanoparticles prepared by nanoprecipitation: drug loading; and release studies of a water soluble drug. J. Control. Release 1999, 99, 171.
   Google Scholar
• Dong, Y.; Feng, S.-S. Methoxy poly(ethylene glycol)–poly(lactide) (MPEG–PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004, 25, 2843.
   PubMed Web of Science ®Google Scholar
• Gref, R.; Domb, A.; Quellec, P.; Blunk, T.; Müller, R. H.; Verbavatz, J. M.; Langer, R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 1995, 16, 215.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Yang, Y.; Liang, X.; Zeng, X.; Liu, Z.; Tao, W.; Xiao, X.; Chen, H.; Huang, L.; Mei, L. Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics 2014, 4, 1085.
   PubMed Web of Science ®Google Scholar
• Mishra, P.; Nayak, B.; Dey, R. K. PEGylation in anti-cancer therapy: an overview. Asian J. Pharm. Sci. 2016, 11, 337.
   Web of Science ®Google Scholar